Luciole Medical raised $5.5 million for blood oxygen probe

Swiss startup Luciole Medical announced today that it has closed a $5.5 million (CHF 5.3 million) Series A  financing round to begin commercializing its minimally-invasive monitoring probe to measure blood oxygen levels in the brains of patients in intensive care units. New investor SVC Ltd. (a subsidiary of Credit Suisse), led the round with Blue Ocean Ventures, Investiere and B-to-V as co-investors with significant support from existing shareholder Zürcher Kantonalbank. The company will also use some of the money to continue developing a non-invasive patch designed to measure oxygen saturation and blood flow in brain tissue in patients undergoing surgery. “This support from seasoned investors is a transformative step that will allow us to accelerate the development of our next-generation brain monitoring platform,” said Luciole Medical CEO Philippe Dro in a prepared statement. “Our goal is to commercialize these important clinical tools that enable physicians to rapidly access critical information on the oxygenation status of the brain.” Brain oxygenation and blood flow are critical for brain function. Impaired oxygenation in the brain can rapidly lead to severe consequences such as cognitive decline, speech impairment, paralysis, coma and even death. Measuring these parameters in patients and during surgery is vital for the immediate diagnosis and treatment of the patient. Luciole Medical ‘s technology measures oxygenated and de-oxygenated hemoglobin cont...
Source: Mass Device - Category: Medical Devices Authors: Tags: Blog Business/Financial News Funding Roundup Patient Monitoring b-to-v blueoceanventures CreditSuisse investiere luciolemedical svcltd. Source Type: news